Reicansky I, Conradson T B, Holmberg S, Rydén L, Waldenström A, Wennerblom B
Am Heart J. 1976 Jun;91(6):705-11. doi: 10.1016/s0002-8703(76)80535-2.
Patients with acute myocardial infarction were allocated to two groups according to a double blind-system of radomization. The patients (n = 18) in one of the groups received digoxin intravenously as an injection of 0.01 mg. per kilogram of body weight during 10 minutes. The patients in the other group (n = 15) received saline and served as controls. A continuous ECG record was obtained from each patient during 1 hour preceding the administration of digoxin or saline and was continued for 3 hours following the injection. No antiarrhythmic treatment was given during the time of the study. Based on the continuous ECG, calculations were made of the relative incidence of patients with different types of ventricular tachyarrhythmias during the period of observation as well as the percentage of arrhythmia-containing 1 minute intervals observed during this period. There was no statistical difference between the incidence of ventricular tachyarrhythmias in the two groups in the 1 hour period preceding drug injection. The administration of digoxin and saline did not change the incidence of ventricular tachyarrhythmias and there was also no statistically significant difference between the two groups as regards the incidence of patients showing different types of ventricular tachyarrhythmias during the 3 hour period following drug administration, Considering the 1-minute intervals, those without any ventricular premature contractions were less in the digoxin group (92 per cent) than in the saline group (88 per cent; p less than 0.001). Serum levels of digoxin at the end of the observation period were well above what is considered the minimum therapeutic level and in three patients the level approached or reached the toxic range. In these three patients there was still no increased incidence of ventricular tachyarrhythmias. It is concluded that patients with acute myocardial infarction complicated by incipient left ventricular failure do not show an increased sensitivity to an ordinary dose of digoxin as measured by the occurrence of ventricular tachyarrhythmia.
急性心肌梗死患者按照双盲随机系统分为两组。其中一组患者(n = 18)静脉注射地高辛,剂量为每公斤体重0.01毫克,持续10分钟。另一组患者(n = 15)接受生理盐水注射,作为对照组。在注射地高辛或生理盐水前1小时,对每位患者进行连续心电图记录,并在注射后持续记录3小时。研究期间未给予抗心律失常治疗。根据连续心电图,计算观察期内不同类型室性快速性心律失常患者的相对发生率,以及在此期间观察到的含心律失常的1分钟间隔的百分比。在药物注射前1小时,两组室性快速性心律失常的发生率无统计学差异。地高辛和生理盐水的注射并未改变室性快速性心律失常的发生率,并且在给药后3小时内,两组在显示不同类型室性快速性心律失常的患者发生率方面也无统计学显著差异。考虑1分钟间隔,地高辛组无任何室性早搏的患者比例(92%)低于生理盐水组(88%;p<0.001)。观察期末地高辛血清水平远高于公认的最低治疗水平,3例患者的水平接近或达到中毒范围。在这3例患者中,室性快速性心律失常的发生率仍未增加。结论是,以室性快速性心律失常的发生来衡量,合并早期左心室衰竭的急性心肌梗死患者对普通剂量地高辛未表现出更高的敏感性。